IL142444A0 - TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS - Google Patents

TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS

Info

Publication number
IL142444A0
IL142444A0 IL14244499A IL14244499A IL142444A0 IL 142444 A0 IL142444 A0 IL 142444A0 IL 14244499 A IL14244499 A IL 14244499A IL 14244499 A IL14244499 A IL 14244499A IL 142444 A0 IL142444 A0 IL 142444A0
Authority
IL
Israel
Prior art keywords
piperidines
tricyclic
pharmaceuticals
Prior art date
Application number
IL14244499A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL142444A0 publication Critical patent/IL142444A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14244499A 1998-10-06 1999-10-01 TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS IL142444A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06
PCT/EP1999/007420 WO2000020423A1 (en) 1998-10-06 1999-10-01 Tricyclic δ3-piperidines as pharmaceuticals

Publications (1)

Publication Number Publication Date
IL142444A0 true IL142444A0 (en) 2002-03-10

Family

ID=8234192

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14244499A IL142444A0 (en) 1998-10-06 1999-10-01 TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS
IL142444A IL142444A (en) 1998-10-06 2001-04-04 Δ3 - Tricyclic piperidines converted to alkyl are converted in position 1, their preparation and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142444A IL142444A (en) 1998-10-06 2001-04-04 Δ3 - Tricyclic piperidines converted to alkyl are converted in position 1, their preparation and pharmaceutical preparations containing them

Country Status (28)

Country Link
US (1) US6352999B1 (xx)
EP (1) EP1119570B1 (xx)
JP (1) JP4590102B2 (xx)
KR (1) KR20010071844A (xx)
CN (1) CN1131868C (xx)
AR (1) AR023679A1 (xx)
AT (1) ATE269337T1 (xx)
AU (1) AU759199B2 (xx)
BG (1) BG64871B1 (xx)
BR (1) BR9913108A (xx)
CA (1) CA2346082C (xx)
CZ (1) CZ20011105A3 (xx)
DE (1) DE69918148T2 (xx)
EE (1) EE04680B1 (xx)
ES (1) ES2222735T3 (xx)
HK (1) HK1038009A1 (xx)
HU (1) HUP0103749A3 (xx)
ID (1) ID28451A (xx)
IL (2) IL142444A0 (xx)
NO (1) NO20011402L (xx)
NZ (1) NZ510116A (xx)
PL (1) PL347179A1 (xx)
RU (1) RU2226194C2 (xx)
SK (1) SK285386B6 (xx)
TR (1) TR200100953T2 (xx)
TW (1) TWI244485B (xx)
UA (1) UA70961C2 (xx)
WO (1) WO2000020423A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
CA2451606A1 (en) 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
CN1972938B (zh) 2004-04-12 2010-09-29 大正制药株式会社 环状胺化合物
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
KR101595183B1 (ko) 2013-07-25 2016-02-17 동아에스티 주식회사 벤즈아미드 유도체의 제조방법, 그의 제조에 사용되는 새로운 중간체 및 상기 중간체의 제조방법
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
EP0942911B1 (en) * 1996-12-06 2001-10-17 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
HK1038009A1 (en) 2002-03-01
EP1119570B1 (en) 2004-06-16
ATE269337T1 (de) 2004-07-15
SK4332001A3 (en) 2001-12-03
TR200100953T2 (tr) 2001-09-21
NO20011402D0 (no) 2001-03-20
IL142444A (en) 2008-03-20
AU759199B2 (en) 2003-04-10
RU2226194C2 (ru) 2004-03-27
CN1321158A (zh) 2001-11-07
CA2346082A1 (en) 2000-04-13
CZ20011105A3 (cs) 2001-12-12
DE69918148D1 (de) 2004-07-22
ES2222735T3 (es) 2005-02-01
EP1119570A1 (en) 2001-08-01
CN1131868C (zh) 2003-12-24
PL347179A1 (en) 2002-03-25
HUP0103749A3 (en) 2003-03-28
DE69918148T2 (de) 2005-07-28
AU6334299A (en) 2000-04-26
WO2000020423A1 (en) 2000-04-13
NO20011402L (no) 2001-03-20
JP2002526547A (ja) 2002-08-20
KR20010071844A (ko) 2001-07-31
US6352999B1 (en) 2002-03-05
EE200100210A (et) 2002-06-17
UA70961C2 (uk) 2004-11-15
BR9913108A (pt) 2001-05-08
CA2346082C (en) 2010-02-16
EE04680B1 (et) 2006-08-15
AR023679A1 (es) 2002-09-04
BG64871B1 (bg) 2006-07-31
HUP0103749A2 (hu) 2002-02-28
JP4590102B2 (ja) 2010-12-01
TWI244485B (en) 2005-12-01
NZ510116A (en) 2002-10-25
SK285386B6 (sk) 2006-12-07
BG105334A (en) 2001-11-30
ID28451A (id) 2001-05-24

Similar Documents

Publication Publication Date Title
IL137511A0 (en) Novel tricyclic compound
PL341642A1 (en) Novel macrolydes
EA199900301A3 (ru) Замещенные трициклические соединения.
PL345283A1 (en) Biphenyl derivatives
AU3840000A (en) Tricyclic compounds
EP1068213A4 (en) SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
EA199900304A3 (ru) Замещенные трициклические соединения.
PL347894A1 (en) Tricyclic delta 3-piperidines as alpha 2-adrene-receptores
IL142444A0 (en) TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS
HUP0102220A3 (en) Biphenyl derivatives
IL135580A0 (en) Biphenyl derivatives as pharmaceuticals
HUP9903242A3 (en) Special adhesive-bond
EP1105133A4 (en) TRICYCLIC CONNECTIONS
AU2230101A (en) Tricyclic compounds
GB2347433B (en) Compsition
GB2337526B (en) Easy rockeries
GB9828707D0 (en) Pharmaceutical uses
GB9801738D0 (en) Pharmaceuticals
GB9804557D0 (en) Pharmaceuticals
GB9804874D0 (en) Pharmaceuticals
GB9804892D0 (en) Pharmaceuticals
GB9820294D0 (en) Pharmaceuticals
GB9823539D0 (en) Pharmaceuticals
GB2324022B (en) Interlinked watchstrap
AUPP299098A0 (en) Tricyclic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed